Cargando…
In Vitro Activity of the Novel Tetracyclines, Tigecycline, Eravacycline, and Omadacycline, Against Moraxella catarrhalis
BACKGROUND: Tigecycline, eravacycline, and omadacycline are recently developed tetracyclines. Susceptibility of microbes to these tetracyclines and their molecular mechanisms have not been well elucidated. We investigated the susceptibility of Moraxella catarrhalis to tigecycline, eravacycline, and...
Autores principales: | Sun, Xiang, Zhang, Bo, Xu, Guangjian, Chen, Junwen, Shang, Yongpeng, Lin, Zhiwei, Yu, Zhijian, Zheng, Jinxin, Bai, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748099/ https://www.ncbi.nlm.nih.gov/pubmed/33303714 http://dx.doi.org/10.3343/alm.2021.41.3.293 |
Ejemplares similares
-
Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023) -
In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
por: Zhang, Tingting, et al.
Publicado: (2022) -
In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
por: Zeng, Weiliang, et al.
Publicado: (2022) -
Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China
por: Wen, Zewen, et al.
Publicado: (2020) -
Moraxella Catarrhalis peritonitis
por: Sadjadi, Seyed-Ali, et al.
Publicado: (2012)